mementor develops and markets digital medical products in sleep medicine and related fields. Originally founded in 2014 in Switzerland by Dr. Noah Lorenz, Alexander Rötger, Jan Kühni, and Daniel Rotzetter, mementor has its headquarters in Leipzig since January 2020. They offer "Apps on Prescription" to address where conventional patient care reaches its limits, aiming to remove treatment barriers and provide access to evidence-based therapy methods.

Our team aims to equip those affected with effective tools to treat physical or mental illnesses with their digital health products. They contribute to closing existing gaps in healthcare provision and shaping the future of digital medicine. High scientific standards, an evidence-based approach, data protection, and patient safety are priorities.

Information security and patient safety are top priorities. mementor is certified according to the DIN EN ISO/IEC 27001 standard and fulfills all related information security requirements. Through quality management system certification according to DIN EN ISO 13485, mementor demonstrates that all necessary measures are taken to produce high-quality medical devices. Compliance is verified annually through internal and external audits to ensure highest quality and safety.

They have developed somnio, the first permanently approved DiGA (App on Prescription) since October 2020 for treating insomnia, based on cognitive behavioral therapy for insomnia (CBT-I). The app adjusts to personal needs and improves sleep behavior sustainably within three months, with proven effectiveness from randomized scientific studies.

Another product is actensio, a digital health application for hypertension treatment that supports patients in implementing long-term lifestyle changes based on behavioral medicine principles to sustainably lower blood pressure and reduce heart attack and stroke risk, also validated by randomized clinical studies.

Since August 2, 2022, mementor DE GmbH is part of ResMed in Germany. They aim to leverage mutual expertise to provide more people with effective and low-threshold alternative therapy options for sleep disorders and close care gaps. mementor is integrated as a separate business unit of ResMed in Germany and serves as a basis for future developments in digital health. Their founder Dr. Noah Lorenz and Katherina Jekerle, former Senior Director Marketing and managing director member at ResMed Germany, lead the management.